Read How Analysts Reacted To Core & Main’s Q3 Results

Credit Suisse analyst Jamie Cook raised Core & Main Inc (NYSE:CNM) price target to $40 (an upside of 42%) from $33 and maintained…
  • Credit Suisse analyst Jamie Cook raised Core & Main Inc (NYSE:CNM) price target to $40 (an upside of 42%) from $33 and maintained an Outperform rating on the shares.
  • Cook notes that Core & Main was up after beating consensus revenue, EBITDA, and margin estimates, while raising full-year 2021 guidance despite most industrial companies challenged with supply chain and price cost.
  • Baird analyst David Manthey raised the price target to $33 from $32 and maintained an Outperform rating on the shares.
  • Manthey sees a favorable near-term demand/pricing backdrop, with implied guidance well above his prior estimate, while medium/long-term fundamental drivers are positive.
  • Deutsche Bank analyst Rohit Seth raised the price target to $37 (an upside of 31%) from $33 and maintained a Buy rating on the shares.
  • Seth tells investors in a research note that the company “reported another impressive quarterly result.”
  • Seth says Core & Main is “clearly managing the external environment well with supply-demand imbalances and all.”
  • Citi analyst Anthony Pettinari downgraded Core & Main to Neutral from Buy with an unchanged price target of $32 (an upside of 13.6%).
  • Pettinari cites valuation for the downgrade following the period of recent share outperformance. The analyst now sees Core & Main’s risk/reward as “roughly balanced” with fundamentals better reflected in its valuation.
  • Recently, Core & Main reported a Q3 net sales increase of 38.7% year-over-year to $1.4 billion, beating the consensus of $1.29 billion and EPS of $0.39, beating the estimate of $0.30.
  • Gross profit increased by 51.6% Y/Y to $370.6 million, and margin expanded by 230 bps to 26.4%.
  • Adjusted EBITDA increased 83.4% Y/Y to $189.1 million and margin increased 330 basis points to 13.5%.
  • Based on current visibility, the backlog of existing orders, and business trends, the company expects FY21 Adjusted EBITDA of $560 million – $580 million, a year-over-year growth of 64% to 70% (compared to the prior expectation of $470 million – $510 million).
  • Price Action: CNM shares are trading lower by 2.19% at $27.90 on the last check Wednesday.
Total
0
Shares
Related Posts
Read More

Cannabis In New Jersey: How Did The Market Change Since Recreational Weed Was Legalized?

On Thursday, Cantor Fitzgerald analyst Pablo Zuanic offered an update on New Jersey’s recreational cannabis market. Zuanic analyzed the competitive landscape and the changes in the recreational cannabis market in The Garden State. Although the report is not a second-quarter preview, the analyst offered an estimation of the evolution of the state market.

ACRHF